Eed-dependent histone modification orchestrates the iNKT cell developmental program alleviating liver injury
Polycomb repressive complex 2 (PRC2) is an evolutionarily conserved epigenetic modifier responsible for tri-methylation of lysine 27 on histone H3 (H3K27me3). Previous studies have linked PRC2 to invariant natural killer T (iNKT) cell development, but its physiological and precise role remained unclear. To address this, we conditionally deleted Eed, a core subunit of PRC2, in mouse T cells. The results showed that Eed-deficient mice exhibited a severe reduction in iNKT cell numbers, particularly NKT1 and NKT17 cells, while conventional T cells and NKT2 cells remained intact. Deletion of Eed disrupted iNKT cell differentiation, leading to increased cell death, which was accompanied by a severe reduction in H3K27me3 levels and abnormal expression of <i>Zbtb16</i>, <i>Cdkn2a</i>, and <i>Cdkn1a</i>. Interestingly, Eed-deficient mice were highly susceptible to acetaminophen-induced liver injury and inflammation in an iNKT cell-dependent manner, highlighting the critical role of Eed-mediated H3K27me3 marks in liver-resident iNKT cells. These findings provide further insight into the epigenetic orchestration of iNKT cell-specific transcriptional programs.
Authors
- Shun Ohki (ORCID: https://orcid.org/0000-0001-6301-8919)
- Masamoto Kanno (ORCID: https://orcid.org/0000-0001-9169-3444)
- Tomoharu Yasuda (ORCID: https://orcid.org/0000-0001-9997-6852)
- Yohei Kawano (ORCID: https://orcid.org/0000-0001-7181-2282)
- Yun Guo (ORCID: https://orcid.org/0000-0002-8107-0507)
- Yoshinori Ohno
- Weng Sheng Kong
- Hiroaki Honda
Institutions
- Hiroshima University (JP)
- Japan Agency for Medical Research and Development (JP)
- Fukuoka University (JP)
- Tokyo Women's Medical University (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-20
- DOI
- https://doi.org/10.3389/fimmu.2024.1467774
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science